If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
This Amendment No. 1 to Schedule 13D relates to the common shares ("Shares") of PRIMECAP Odyssey Discovery ETF ("POMG"), and amends the initial statement on Schedule 13D filed by the undersigned on October 26, 2026, as specifically set forth herein. This Amendment No. 1 is being filed to reflect a decrease in beneficial ownership of Shares by the Reporting Persons as a result of the 2,060,000 Shares of POMG outstanding on October 30, 2026.


SCHEDULE 13D


 
Molinelli Gregory Todd
 
Signature:/s/Gregory Molinelli
Name/Title:Gregory Molinelli, Executive Vice President
Date:11/02/2026